Nuke if you listen to the ASM webcast SK says that the pancreatic trial has NOT reached MOS...will do so "later this year or early next year" around the 6:52 point.
nuke, here are my notes: gawd knows what some of it meana: PII pancreatic ca w gemcitabine not clear how drug was tracking. MOS to be reached late this year or early next year. Too early to tell. Pancreatic: completed enrollment June this year. Primary endpoint MOS “WHEN? end of this year or beginning next year.